Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice

Phytomedicine

Volumn 16, Issue 6-7, 2009, Pages 538-546

  Li, Hongzhong ^a   Gong, Xia ^a   Zhang, Li ^a   Zhang, Zhuo ^a   Luo, Fuling ^a   Zhou, Qixin ^a   Chen, Jin ^a   Wan, Jingyuan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Centella asiatica; Collagen induced arthritis; IL 10; Madecassoside; Pro inflammatory cytokines; Rheumatoid arthritis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COLLAGEN TYPE 2; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 6; MADECASSOSIDE; PROSTAGLANDIN E2; TRITERPENOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; HINDLIMB; HISTOLOGY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PAW EDEMA; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SPLEEN CELL; SYNOVIUM; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOKINES; DINOPROSTONE; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED DBA; SYNOVIAL MEMBRANE; TRITERPENES;

BOVINAE; CENTELLA ASIATICA; MUS;

EID: 67349229123     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.11.002     Document Type: Article

References (52)

1. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54 (1993) 1
2. Andreakos E.T., Foxwell B.M., Brennan F.M., Maini R.N., and Feldmann M. Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev. 13 (2002) 299
3. Bian G.X., Li G.G., Yang Y., Liu R.T., Ren J.P., Wen L.Q., Guo S.M., and Lu Q.J. Madecassoside reduces ischemia-reperfusion injury on regional ischemia induced heart infarction in rat. Biol. Pharm. Bull. 31 (2008) 458
4. Brentano F., Kyburz D., Schorr O., Gay R., and Gay S. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol. 233 (2005) 90
5. Brinkhaus B., Lindner M., Schuppan D., and Hahn E.G. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine 7 (2000) 427
6. Butler D.M., Maini R.N., Feldmann M., and Brennan F.M. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti-TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur. Cytokine Network 6 (1995) 225
7. Choy E.H., and Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344 (2001) 907
8. Dayer J.M., and Fenner H. The role of cytokines and their inhibitors in arthritis. Baillieres Clin. Rheumatol. 6 (1992) 485
9. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209
10. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14 (1996) 397
11. Firestein G.S. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J. Clin. Rheumatol. 11 (2005) S39
12. Fournier C. Where do T cells stand in rheumatoid arthritis?. Jt. Bone Spine 72 (2005) 527
13. Gabriel S.E. The epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27 (2001) 269
14. Goldenberg M.M. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clin. Ther. 21 (1999) 1497
15. Goldring M.B. The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 43 (2000) 1916
16. Goldring S.R., and Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. (2004) S27
17. Günther B., and Wagner H. Quantitative determination of triterpenes in extracts and phytopreparations of Centella asiatica (L.) Urban. Phytomedicine 3 (1996) 59
18. Houssiau F.A., Devogelaer J.P., Van Damme J., de Deuxchaisnes C.N., and Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31 (1988) 784
19. Iannone F., De Bari C., Dell'Accio F., Covelli M., Cantatore F.P., Patella V., Lo Bianco G., and Lapadula G. Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin. Exp. Rheumatol. 19 (2001) 139
20. Jayathirtha M.G., and Mishra S.H. Preliminary immunomodulatory activities of methanol extracts of Eclipta alba and Centella asiatica. Phytomedicine 11 (2004) 361
21. Jia G., and Lu X. Enrichment and purification of madecassoside and asiaticoside from Centella asiatica extracts with macroporous resins. J. Chromatogr. A 1193 (2008) 136
22. Joyce D.A., Gibbons D.P., Green P., Steer J.H., Feldmann M., and Brennan F.M. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur. J. Immunol. 24 (1994) 2699
23. Kannan K., Ortmann R.A., and Kimpel D. Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology 12 (2005) 167
24. Karouzakis E., Neidhart M., Gay R.E., and Gay S. Molecular and cellular basis of rheumatoid joint destruction. Immunol. Lett. 106 (2006) 8
25. Katori M., and Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm. Res. 49 (2000) 367
26. Katsikis P.D., Chu C.Q., Brennan F.M., Maini R.N., and Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179 (1994) 1517
27. Liu M.R., Han T., Chen Y., Qin L.P., Zheng H.C., and Rui Y.C. Effect of madecassoside on depression behavior of mice and activities of MAO in different brain regions of rats. Zhong Xi Yi Jie He Xue Bao 2 (2004) 440
28. Martel-Pelletier J., Pelletier J.P., and Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin. Arthritis Rheum. 33 (2003) 155
29. Mastbergen S.C., Lafeber F.P., and Bijlsma J.W. Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology (Oxford) 41 (2002) 801
30. Matsuda H., Morikawa T., Ueda H., and Yoshikawa M. Medicinal foodstuffs. XXVII. Saponin constituents of gotu kola (2): structures of new ursane- and oleanane-type triterpene oligoglycosides, centellasaponins B, C, and D, from Centella asiatica cultivated in Sri Lanka. Chem. Pharm. Bull. (Tokyo) 49 (2001) 1368
31. Miossec P. Cytokine abnormalities in inflammatory arthritis. Baillieres Clin. Rheumatol. 6 (1992) 373
32. Miossec P. An update on the cytokine network in rheumatoid arthritis. Curr. Opin. Rheumatol. 16 (2004) 218
33. Mitchell D.M., Spitz P.W., Young D.Y., Bloch D.A., McShane D.J., and Fries J.F. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 29 (1986) 706
34. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683
35. O'Neill G.P., and Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330 (1993) 156
36. Park J.Y., Pillinger M.H., and Abramson S.B. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119 (2006) 229
37. Pribytkov Iu N., Korshunov N.I., and Frizen B.N. Prostaglandins in the blood serum of patients with rheumatoid arthritis. Ter Arkh. 63 (1991) 86
38. Sampson J.H., Raman A., Karlsen G., Navsaria H., and Leigh I.M. In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. Phytomedicine 8 (2001) 230
39. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., and Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91 (1994) 12013
40. Sengupta T.K., Chen A., Zhong Z., Darnell Jr. J.E., and Ivashkiv L.B. Activation of monocyte effector genes and STAT family transcription factors by inflammatory synovial fluid is independent of interferon gamma. J. Exp. Med. 181 (1995) 1015
41. Smolen J.S., and Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat. Rev. Drug Discov. 2 (2003) 473
42. Smolen J.S., Breedveld F.C., Eberl G., Jones I., Leeming M., Wylie G.L., and Kirkpatrick J. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum. 38 (1995) 38
43. Sokka T. Work disability in early rheumatoid arthritis. Clin. Exp. Rheumatol. 21 (2003) S71
44. Sweeney S.E., and Firestein G.S. Rheumatoid arthritis: regulation of synovial inflammation. Int. J. Biochem. Cell Biol. 36 (2004) 372
45. Tak P.P., Smeets T.J., Daha M.R., Kluin P.M., Meijers K.A., Brand R., Meinders A.E., and Breedveld F.C. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 40 (1997) 217
46. Tak P.P., Gerlag D.M., Aupperle K.R., van de Geest D.A., Overbeek M., Bennett B.L., Boyle D.L., Manning A.M., and Firestein G.S. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum. 44 (2001) 1897
47. Tomita T., Kakiuchi Y., and Tsao P.S. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis. Arthritis Res. Ther. 8 (2006) R7
48. Tran C.N., Lundy S.K., and Fox D.A. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12 (2005) 183
49. Williams R.O., Feldmann M., and Maini R.N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89 (1992) 9784
50. Wong M., Ziring D., Korin Y., Desai S., Kim S., Lin J., Gjertson D., Braun J., Reed E., and Singh R.R. TNFalpha blockade in human diseases: mechanisms and future directions. Clin. Immunol. 126 (2008) 121
51. Yoshimura A., Mori H., Ohishi M., Aki D., and Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr. Opin. Immunol. 15 (2003) 704
52. Yoshizaki K., Nishimoto N., Mihara M., and Kishimoto T. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody. Springer Semin. Immunopathol. 20 (1998) 247